Inventing Tomorrow Today
Fortune Magazine selects MDPad as one of five companies “who weren’t just talking about what the future might be like but were actually inventing it.”


Home | Products | Solutions | About MDPad | News | Users | Register
  Practice Management
  Order Entry
  Charge Capture
and Billing
  Group Collaboration
  Universal Medical
  Virtual Provider
Case Studies
White Papers

White Paper on Physician Order Entry with Decision Support

98,000 Americans die each year as a result of medical mistakes – Institutes Of Medicine

MDPad provides many critical benefits to the ordering process so as to minimize the risk of medical mistake.

 Formulary Compliance – clear information at the time of prescribing of alternate products on the patient’s formulary and consistent with the provider group’s formulary can dramatically increase compliance.
 Errors of Communication – illegible orders, orders not transmitted to appropriate parties, duplicate administration of medications.
 Best Clinical Practices - e.g. “CAD? Aspirin saves lives” to patient on a statin but not on an aspirin, "CHF? ACE-I save lives" to patient being given a CHF med but not on an ACE-I. Each piece also includes a focused and concise discussion of the pertinent medical literature with references as well as next step orders.
 Drug-Drug Interactions - e.g. Bactrim & Coumadin, Amikacin & Ceftriaxone, Amiodarone & Fentanyl, Nardil & Meridia, Quinidine & Ciprofloxacin, Coumarin & Amiodarone. Each piece with next step orders such as “Check PT (INR) in 3 days” or “Alternate Antibiotics by Indication” for “Coumarins & Sulfonamides => bleeding”.
 Cross-Allergy Warnings e.g. amoxicillin to patient allergic to ampicillin, sulfa allergies with next step orders.
 Dosage Guidelines – maximum dosage, minimum dosage by indication, adjustment for renal and hepatic insufficiency.
 Therapeutic Duplication - e.g. lisinopril to patient on enalapril.
 Managed Prior Authorization Information - e.g. requirements for a new start patient on COX-2 with ability to produce authorization letters.
 Drug Utilization Review - e.g. Prilosec being prescribed to a patient who has not tried Zantac.
 Alternate Therapeutics - e.g. "ACE-I intolerant? Role of ARBs" to patients who are allergic to or were previously on an ACE-I but not on an ARB.